Histopathological and immunophenotypic features of ipilimumab‐associated colitis compared to ulcerative colitis

Background Use of the immune checkpoint inhibitor ipilimumab is sometimes complicated by ipilimumab-associated colitis (Ipi-AC), an immune-mediated colitis that mimics inflammatory bowel disease.